Clinical data | |
---|---|
Pronunciation | /pəˈpævəriːn/ |
Trade names | Pavabid, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682707 |
Pregnancy category |
|
Routes of administration | Oral, intravenous, intramuscular, rectal, intracavernosal |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 80% |
Protein binding | ~90% |
Metabolism | Hepatic |
Elimination half-life | 1.5–2 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.361 |
Chemical and physical data | |
Formula | C20H21NO4 |
Molar mass | 339.391 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Papaverine (Latin papaver, "poppy") is an opium alkaloid antispasmodic drug, used primarily in the treatment of visceral spasms and vasospasms (especially those involving the intestines, heart, or brain), occasionally in the treatment of erectile dysfunction and acute mesenteric ischemia. While it is found in the opium poppy, papaverine differs in both structure and pharmacological action from the analgesic morphine and its derivatives (such as codeine).
In addition to opium, papaverine is purported to be present in high concentrations in star gooseberry.[1]